One-year medication for select patients without full cover – Gulf News

Patients with Multiple Sclerosis, Pulmonary Arterial Hypertension among those covered

Dubai: The Ministry of Health and Prevention, MoHAP, recently signed a memorandum of understanding (MoU) with Bayer Middle East and Axios Health Education Services to provide one-year medication for patients with Multiple Sclerosis, Pulmonary Arterial Hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH) in cases where medical insurance doesnt cover the total cost of treatment.

The MoU is part of Dam initiative (support) launched by MoHAP in 2018.

The agreement was signed by Dr Amin Hussein Al Amiri, Assistant Undersecretary of the Ministry of Health and Preventions Public Health Policy and Licenses, Henrik Wulff, Managing Director, Bayer Middle East and Anas Al-Safarini, Executive Director for the Middle East and North Africa, Axios Health Education Services.

Dr Ruqaya pointed to the importance of renewing the initiative for the second consecutive year and stressed on MoHAPs keenness to mitigate a patients suffering, especially when insurance does not covering the total cost of treatment.

The MoU also covers non-insured patients or those with partial insurance coverage.

Henrik Wulff said Bayer seeks to bolster MoHAPs efforts in ensuring patients adhere to their treatment plans.

Anas Al-Safarini spoke on Axioss commitment to coordinate with charities and partners to ensure the seamless progress of the programme in addition to managing patients treatment journey through constant communication.

Read more from the original source:

One-year medication for select patients without full cover - Gulf News